Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Forazapadin

Small molecule · Inhibitor of AAK1 (AP2-associated kinase 1) (AAK1) · developed by Satellos Bioscience

Phase 2 Most advanced trial
MSLE Developer
1 Registered trials

What is Forazapadin?

Forazapadin is an orally available, muscle-penetrant small molecule that inhibits AAK1, a kinase. It is being studied in facioscapulohumeral muscular dystrophy (FSHD).

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Targets
AAK1 (AP2-associated kinase 1) (AAK1)
Mechanism
Inhibitor of AAK1 (AP2-associated kinase 1) (AAK1)
Therapy area
Musculoskeletal
Developer
Satellos Bioscience, Inc. (MSLE)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2
UNII
7YS2892UYA

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07872306 Phase 2 Facioscapulohumeral Muscular Dystrophy (FSHD) Not yet recruiting MSLE

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Facioscapulohumeral Muscular Dystrophy (FSHD)

Other drugs acting on AAK1

More from Satellos Bioscience

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the MSLE page.

Follow MSLE, the company behind Forazapadin

See MSLE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

MSLE catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.